Oncotarget

Vol 11, No 38

September 22, 2020

View Archive »

Order a Reprint

About The Cover

The cover for issue 38 of Oncotarget features Figure 3, "Summary of the time and cost for drug development (modified from DiMasi et al [2016]," by Katayama, et al.

Table of Contents

Research Perspectives

Targeting desmoplasia in pancreatic cancer as an essential first step to effective therapy

Targeting desmoplasia in pancreatic cancer as an essential first step to effective therapy

https://doi.org/10.18632/oncotarget.27745

Nancy D. Ebelt, Vic Zamloot,  and Edwin R. Manuel
3486-3488
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint

Research Papers

A comprehensive analysis of clinical trials in pancreatic cancer: what is coming down the pike?

A comprehensive analysis of clinical trials in pancreatic cancer: what is coming down the pike?

https://doi.org/10.18632/oncotarget.27727

Erryk S. Katayama, Jonathan J. Hue, David L. Bajor, Lee M. Ocuin, John B. Ammori, Jeffrey M. Hardacre,  and Jordan M. Winter
3489-3501
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Podcast  |  Order a Reprint

Pharmacological targeting of mitochondrial function and reactive oxygen species production prevents colon 26 cancer-induced cardiorespiratory muscle weakness

Pharmacological targeting of mitochondrial function and reactive oxygen species production prevents colon 26 cancer-induced cardiorespiratory muscle weakness

https://doi.org/10.18632/oncotarget.27748

Ashley J. Smuder, Brandon M. Roberts, Michael P. Wiggs, Oh Sung Kwon, Jeung-Ki Yoo, Demetra D. Christou, David D. Fuller, Hazel H. Szeto,  and Andrew R. Judge
3502-3514
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Altered lung tissue lipidomic profile in caspase-4 positive non-small cell lung cancer (NSCLC) patients

Altered lung tissue lipidomic profile in caspase-4 positive non-small cell lung cancer (NSCLC) patients

https://doi.org/10.18632/oncotarget.27724

Michela Terlizzi, Antonio Molino, Chiara Colarusso, Pasquale Somma, Ilaria De Rosa, Jacopo Troisi, Giovanni Scala, Rosario Salvi, Aldo Pinto,  and Rosalinda Sorrentino
3515-3525
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Order a Reprint

A low psoas muscle volume is associated with a poor prognosis in penile cancer

A low psoas muscle volume is associated with a poor prognosis in penile cancer

https://doi.org/10.18632/oncotarget.27719

Daiji Takkamoto, Takashi Kawahara, Takashi Tokita, Jun Kasuga, Yasushi Yumura,  and Hiroji Uemura
3526-3530
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Order a Reprint

Reviews

Advances in epidermal growth factor receptor specific immunotherapy: lessons to be learned from armed antibodies

Advances in epidermal growth factor receptor specific immunotherapy: lessons to be learned from armed antibodies

https://doi.org/10.18632/oncotarget.27730

Fleury Augustin Nsole Biteghe, Neelakshi Mungra, Nyangone Ekome Toung Chalomie, Jean De La Croix Ndong, Jean Engohang-Ndong, Guillaume Vignaux, Eden Padayachee, Krupa Naran,  and Stefan Barth
3531-3557
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint

Corrections

Correction: Melatonin attenuated the brain damage and cognitive impairment partially through MT2 melatonin receptor in mice with chronic cerebral hypoperfusion

Correction: Melatonin attenuated the brain damage and cognitive impairment partially through MT2 melatonin receptor in mice with chronic cerebral hypoperfusion

https://doi.org/10.18632/oncotarget.27754

Tzu-Hsien Tsai, Cheng-Jei Lin, Sarah Chua, Sheng-Ying Chung, Cheng-Hsu Yang, Meng-Shen Tong,  and Chi-Ling Hang
3558-3558
Correction  |  PDF  |  How to cite


Copyright © 2020 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC